JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Wheezy baby syndrome--a possible sequelae of neonatal meconium aspiration syndrome.

Forty children aged 5 months to 3 years and suffering from wheezy baby syndrome (WBS) were evaluated to find out the prevalence of neonatal meconium aspiration syndrome (MAS) from the birth records. Twelve (30%) babies with WBS were detected to have a history of MAS at birth, significant enough to require a neonatal ICU admission. In contrast, only 2% of the 50 control non wheezy babies aged 6 months-3 years had a history of neonatal meconium aspiration syndrome (p less than 0.001). There was no significant difference in mean number of wheezing spells over six months in the neonatal MAS positive and MAS negative groups (3.4 vs. 3.2, p greater than 0.05). Family history of atopy was present in 64.3% of wheezing subjects with normal birth records, while none had such history in babies with neonatal MAS. The results of the present study suggested an association between neonatal MAS and subsequent wheezing.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app